Anemia in chronic renal disease: Evaluation of inflammatory activity on erythropoiesis and iron metabolism in patients not submitted to dialysis treatment

Clinical Laboratory

Volumn 58, Issue 7-8, 2012, Pages 695-704

  De Lima, Gisélia A F M ^a   Mazzali, Marilda ^a   Alves Filho, Gentil ^a   Plotegher, Lucas ^a   Grotto, Helena Z W ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Anemia of chronic disease; Interleukin; Iron deficiency anemia; Iron metabolism; Neopterin; Renal failure

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; IRON; NEOPTERIN;

ADULT; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIALYSIS; ERYTHROPOIESIS; HUMAN; INFLAMMATION; IRON DEFICIENCY ANEMIA; IRON METABOLISM; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; RENAL ANEMIA; RETICULOCYTE HEMOGLOBIN CONTENT;

ADULT; ANEMIA; ERYTHROPOIESIS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; IRON; KIDNEY FAILURE, CHRONIC; NEOPTERIN; RENAL DIALYSIS;

EID: 84866090044     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2011.110210     Document Type: Article

References (34)

1. National Kidney Foundation. Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006;47 (5Suppl3):S1-S146.
2. Malyszko J, Mysliwiec M. Hepcidin in anemia and inflammation in chronic kidney disease. Kidney Blood Press Re 2007;30:15-30.
3. Caro J, Erslev AJ. Anemia of chronic renal failure. In: Beutler E, Lichtman MA, Cloor BS, Kipps TJ, editors. Hematology. New York: McGraw-Hill Medical Publishing Division,2001:399-405.
4. Hsu C-Y, McCulloch CE, Curhan GC. Iron status and hemoglobin level in chronic renal insufficiency. J Am Soc Nephrol 2002; 13:2783-86.
5. Weiss G. Pathogenesis and treatment of anemia of chronic disease. Blood Rev 2002;16:87-6.
6. Wang CQ, Udupa KB, Lipschitz DA. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. J Cell Physiol 1995; 162:134-8.
7. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1898;27:81-141.
8. Pagel H, Fandrey J, Schobesberger W, Fuchs D, Jelkmann W. Effects of neopterin and 7,8-dihydroneoterin on hypoxia-induced renal erythropoiesis production. Eur J Haematol 1999;62:341-5.
9. Ganz T. Hepcidin - a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 2005;18:171-82.
10. Nemeth E, Turtle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3.
11. Buttarello M, Pejola R, Novello E, et al. Diagnosis of iron deficiency in patients undergoing hemodialysis. Am J Clin Pathol 2010;133:949-54.
12. Bovy C, Gothot A, Delanave P, Warling X, Krzesinski JM, Beguin Y. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrol Dial Transplant 2007;22(4):1156-62.
13. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(Suppl1):S1-S266.
14. David O, Grillo A, Ceoloni B, et al. Analysis of red cell parameters on the Sysmex XE 2100 and ADVIA 120 in iron deficiency and in uraemic chronic disease. Scand J Clin Lab Invest 2006; 66:113-20.
15. Jayaranee S, Sthaneshwar P. RET-Y and RBC-Y in the diagnosis of iron deficiency associated with anaemia of inflammation. Int J Hematol 2010:32(5):512-8.
16. Grotto HZW. Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Med Oncol 2008;25(1):12-21.
17. Radtke HW, Claussner A, Erbes PM, Scheuermann EH, Schoeppe W, Koch KM. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood 1979; 54:877-84.
18. Obrador GT, Roberts T, St Peter WL, Frazier E, Pereira BJ, Collins AJ. Trends in anemia at initiation of dialysis in the United States. Kidney Int 2001; 60:1875-84.
19. Kazmi WH, Kausz AT, Khan S, et al. Anemia: an early complication of chronic renal insufficiency. Am J Kidney Dis 2001;38: 803-12.
20. Piva E, Brugnara C, Chiandetti L, Plebani M. Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis. Clin Chem Lab Med 2010;48(10): 1369-80.
21. Brugnara C, Zurakowski D, Dicanzio J, Boyd T, Platt O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA 1999;281, 2225-30.
22. Ullrich 2005, Wu A, Armsby C, et al. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA 2005;294(8):924-30.
23. Brugnara C, Zelmanovic D, Sorette M, Ballas SK, Platt O. Reticulocyte Hemoglobin: An integrated parameter for evaluation of erythropoietic activity. Am J Clin Pathol 1997;108:133-42.
24. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor, ferritin and TfR-F index in identification of latent iron deficiency. Eur J Haematol 1998;60:135-7.
25. Weiss G, Goodnough LT. Medical progress: Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
26. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002;48:1066-76.
27. Pecoits-Filho R, Heimbürger O, Bá;rá;ny P,et al. Associations Between Circulating Inflammatory Markers and Residual Renal Function in CRF Patients. Am J Kidney Dis 2003;41:1212-8.
28. Lhee HY, Kim H, Joo KJ, Jung SS, Lee KB. The clinical significance of serum and urinary neopterin levels in several renal diseases. J Korean Med Sci 2006;21(4):678-82.
29. Jelkmann W. Pro-inflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res 1998;18:555-9.
30. Sucher R, Schroecksnadel K, Weiss Q, Margreiter R, Fuchs D, Brandacher G. Neopterin, a prognostic marker in human malignancies. Cancer Letters 2010;287:13-22.
31. Souza LR, Costa FF, Saad STO, Grotto HZW. High levels of neopterin and interleukin-3 in Sickle Cell Disease patients. J Clin Lab Analysis 2006;20:75-9.
32. Weimer R, Süsal C, Yildiz S, et al. Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens. Am J Transplant 2006; 6(8):1865-74.
33. Avci E, Coskun S, Cakir E, et al. Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients. Ren Fail 2008;30(8):784-90.
34. Basile JN. Clinical considerations and practical recommendations for the primary care practitioner in the management of anemia of Chronic Kidney Disease. Southern Med J 2007;100(11):1200-7.